Showing results (481-490 of 749) with videos related to

Sort By:
Pageof 75
Journal of Immunoassay & Immunochemistry|February 12, 2025
A family cluster of persistent Pandoraea vervacti infection in cystic fibrosisCamilla Bitossi, Matteo Fracella, Agnese Viscido, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 1, 2013
Noise-induced hearing loss (NIHL) as a target of oxidative stress-mediated damage: cochlear and cortical responses after an increase in antioxidant defenseAnna Rita Fetoni, Paola De Bartolo, Sara Letizia Maria Eramo, et al.
Cancer Treatment Reviews|April 2, 2021
Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trialsE F Giunta, G Bregni, A Pretta, et al.
JAMA Psychiatry|April 9, 2025
Automating the Addiction Behaviors Checklist for Problematic Opioid Use IdentificationAngus H Chatham, Eli D Bradley, Vanessa Troiani, et al.
Transplantation Proceedings|December 23, 2018
Survival After Lung Transplant for Cystic Fibrosis in Italy: A Single Center Experience With 20 Years of Follow-upD Savi, M Mordenti, E Bonci, et al.
Journal of Translational Medicine|November 27, 2019
Renal involvement and metabolic alterations in adults patients affected by cystic fibrosisSilvia Lai, Sandro Mazzaferro, Anna Paola Mitterhofer, et al.
Oncotarget|April 19, 2017
Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFRCarminia Maria Della Corte, Umberto Malapelle, Elena Vigliar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Investigation of two dosing schedules of vandetanib (ZD6474), an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, in combination with irinotecan in a human colon cancer xenograft modelTeresa Troiani, Natalie J Serkova, Daniel L Gustafson, et al.
Clinical Colorectal Cancer|February 1, 2022
Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survivalDavide Ciardiello, Vincenzo Famiglietti, Stefania Napolitano, et al.
Life (Basel, Switzerland)|September 27, 2025
Extraneural Soft Tissue Perineurioma of the Oral Cavity: A Rare Case with Medico-Legal Implications and Literature ReviewDaniele Pergolini, Mohamed Mohsen, Simona Zaami, et al.
Pageof 75